Research programme: vestibular disorder therapeutics - Griffin Discoveries/SensorionAlternative Names: H4R antagonist - Griffin Discoveries
Latest Information Update: 19 Jul 2016
At a glance
- Originator Griffin Discoveries; Sensorion
- Mechanism of Action Histamine H4 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Ear disorders
Most Recent Events
- 19 Jul 2016 Early research is still underway in the European Union